tirzepatide 40 MG Peptide, Powder, at ₹ 4500/vial | Mounjaro in Nagpur GLP-1 Compounded Tirzepatide for Weight

Vitamin D deficiency in alopecia areata

Will subtle scars appear that todays short trials are unable to reveal

sitagliptin Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

Supporting Sustainable Fat Loss: With reduced calorie intake and improved metabolism, your body will start tapping into stored fat for energy, leading to steady, healthy, sustainable weight loss

In late December 2025, the FDA approved the first oral GLP-1 medication, a Wegovy (semaglutide) pill